JINGXIN(SZ:002020) Sou Hu Cai Jing·2025-08-13 08:53Group 1 - The core stock price of Jingxin Pharmaceutical (002020) closed at 19.98 yuan, with a slight increase of 0.15% as of August 13, 2025 [1] - The trading volume was 334,300 hands, with a total transaction amount of 666.5 million yuan [1] - The net inflow of main funds was 35.697 million yuan, accounting for 5.37% of the transaction amount, with significant contributions from large orders [1] Group 2 - For the first quarter of 2025, Jingxin Pharmaceutical reported total operating revenue of 956 million yuan, a year-on-year decrease of 9.86% [1] - The net profit attributable to shareholders was 163 million yuan, down 4.62% year-on-year, while the non-recurring net profit was 147 million yuan, a decrease of 6.45% [1] - The company's liquidity ratios include a current ratio of 1.423 and a quick ratio of 0.992, with a debt-to-asset ratio of 28.33% [1] Group 3 - Jingxin Pharmaceutical, established in 1999 and located in Shaoxing, primarily engages in the pharmaceutical manufacturing industry [1] - The company has a registered capital of 8.6102914 billion yuan and has made investments in 24 enterprises [2] - The company has participated in 5,000 bidding projects and holds 293 trademark registrations and 225 patents, along with 149 administrative licenses [2]